CaliPharms, Inc.
KGET
$0.00
$0.000.00%
| 09/30/2014 | 06/30/2014 | 09/30/2013 | |||
|---|---|---|---|---|---|
| Net Income | -218.95% | -67.35% | 100.00% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -30.82% | -36.35% | -- | ||
| Total Other Non-Cash Items | 923.26% | 45.31% | -100.00% | ||
| Change in Net Operating Assets | -241.66% | 129.03% | -100.00% | ||
| Cash from Operations | -44.62% | 30.55% | -- | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -20.08% | -3.91% | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -20.08% | -3.91% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -200.48% | 383.63% | -- | ||
